http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-822966-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea7da26cb077e35d67c7703ba5e49d7d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S516-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-185
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-24
filingDate 1957-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1959-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-822966-A
titleOfInvention Manufacture of n,n-disubstituted amides of aryl acetic acids
abstract The invention comprises N,N-disubstituted arylacetic acid amides of the general formula <FORM:0822966/IV (a)/1> (wherein R is an aryl group which may contain halogen, alkyl and alkoxy substituents, R1 and R2 are each an alkyl, aralkyl, alicyclic, heterocyclic or dialkylaminoalkyl group, and R3 is a dialkylamino, -N-morpholino, -N-piperidino, -N-piperazino, -N-pyrrolidino, <FORM:0822966/IV (a)/2> or <FORM:0822966/IV (a)/3> group) and the acid addition and quaternary ammonium salts of these compounds when amines (but excluding those compounds described and claimed in Specification 771,814), and the preparation thereof by reacting an amide of the formula R-CHR1-CO-R3 with a compound R2Y (wherein Y is a halogen) in substantially equimolecular proportions in the presence of a strongly basic condensing agent and, if desired, converting the products, when amines, into acid addition and quaternary ammonium salts. Advantageously, the condensation is carried out in an inert solvent such as benzene, toluene, xylene or dioxan, suitable condensing agents being, for example, sodium or potassium amide, phenyl sodium or sodium hydride. Examples describe the preparation of a - phenyl - a - (2 - thenyl) - g - dimethylaminobutyric acid diethylamide, a -benzyl-a -(2-morpholinoethyl) - phenanthryl - 31 - acetic acid diethylamide, a -benzyl-a -(2-morpholinoethyl) - naphthyl - 11 - acetic acid di - isopropylamide, a ,a - bis - (dimethylaminoethyl) - phenylacetic acid diethylamide dihydrochloride and a - benzyl - a - (2 - morpholinoethyl) - N - n - propyl - N - benzyl - phenylacetic acid amide; the following are listed, in some cases with physical constants: a - benzyl - a - (2-dimethylaminoethyl) - phenylacetic acid dimethylamide, a - benzyl - a - (2 - diethylamino-ethyl) - phenylacetic acid diethylamide, a -(3,3 - dimethylaminobutyl) - a - (21 - dimethylaminoethyl) - phenylacetic and diethylamide, a - (3,3 - dimethylbutyl) - a - (31 - diethylaminopropyl) - phenylacetic acid diethylamide, a - cyclohexyl - a - (2 - morpholinoethyl)-and (3 - diethylaminopropyl) - phenylacetic acid diethylamide, a ,a -bis-(2-dimethylaminoethyl) - phenylacetic acid diethylamide, a - (2 - diethylaminoethyl) - a - ethylphenylacetic acid di - isopropylamide, a - benzyl - a - diethylamino - phenylacetic acid diethylamide, a - diethylamino - a - (3 - diethylaminopropyl) - phenylacetic acid diethylamide, a -benzyl - a - (2 - diethylaminoethyl) - phenylacetic acid piperidide, a -benzyl-a -(2- morpholinoethyl) - phenylacetic acid piperazide and a - ethyl - a - (2 - diethylaminoethyl) - phenylacetic acid N-methylanilide. The products are useful as pharmaceutical agents and as wetting agents.
priorityDate 1956-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419723178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7237
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431981456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450379536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448715498
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154117351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7566642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11007827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448056355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451412631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410550164

Total number of triples: 41.